Shivani Kapur

Hematology | Oncology

3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Outcomes of relapse after teclistamab therapy in multiple myeloma.

Outcomes of relapse after teclistamab therapy in multiple myeloma.

Journal: Blood cancer journal

Published: August 14, 2025

Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma.

Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma.

Journal: Blood advances

Published: July 31, 2025

Outcomes of Radiation Integrated with T-cell-engaging Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma.

Outcomes of Radiation Integrated with T-cell-engaging Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma.

Journal: Blood advances

Published: July 31, 2025

Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma.

Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma.

Journal: Blood advances

Published: July 31, 2025

CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

Journal: Nature medicine

Published: March 25, 2025

Non-tuberculous mycobacterial infections following teclistamab in multiple myeloma.

Non-tuberculous mycobacterial infections following teclistamab in multiple myeloma.

Journal: Haematologica

Published: October 07, 2024

Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma.

Characteristics and outcomes of therapy-related acute leukemia following autologous transplant (Auto-HCT) for multiple myeloma.

Journal: Bone marrow transplantation

Published: May 21, 2024

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 16, 2023

Unusual Tissue - Unusual Issue: Pancreatic Heterotopia Presenting as Gastric Outlet Obstruction.

Unusual Tissue - Unusual Issue: Pancreatic Heterotopia Presenting as Gastric Outlet Obstruction.

Journal: Case reports in gastroenterology

Published: October 03, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026